ALPHA TRIBE

Akzo Nobel India LimitedImportant, 07-02-2025: Financial Result Updates

07-02-2025 | 12:35 pm

**Consolidated Financials for Akzo Nobel India Limited for the quarter and nine months ended 31 December 2024:**

Revenue from operations for Q3 FY25 was ₹1,050.5 crore, showing a growth of 2% year-over-year. Total income also rose to ₹1,056.5 crore, reflecting operational resilience despite challenging market conditions. For the nine months ending December 2024, revenue from operations grew by 3% to ₹3,069.1 crore, contributing to a total income of ₹3,075 crore.

Net profit for Q3 FY25 fell to ₹108.6 crore, down by 5% compared to the previous year, while net profit for the nine-month period edged up to ₹321.1 crore, reflecting minimal growth of 1%. The Earnings Per Share (EPS) for Q3 amounted to ₹23.85.

Operational costs showed a rise in material costs, which increased 3% year-over-year to ₹5,092 crore. However, total expenses increased by only 2.9%, indicating effective cost management strategies. The company reported total expenses of ₹9,103 crore, with significant contributions from employee benefits and overheads.

Strong balance sheet management and cash flow continue to affirm financial stability, crucial for navigating market uncertainties. With increasing focus on cost control and innovation in product offerings, the strategic outlook remains positive.

Given the current financial performance, Akzo Nobel India appears to present a **hold** opportunity, showcasing a resilient operational structure while addressing challenges in profitability and cost pressures. Future growth potential seems linked to volume recovery and ongoing market share gains.

No comments yet. Be the first to comment!

All announcements from Akzo Nobel India Limited